United States · Venture startup

Who invested in CytoSPAR

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 15 Nov 2026

$2.0Mraised across 1 round since 2022, from 1 source

Latest round
Venture, $2.0MMay 2022
Investors
0
See who backed them

The rounds

  1. May 2022
    Venture$2.0M

    No investor was named in the report.

    Source recordedSEC filing: $2.0M sold, first sale Apr 2022

Funding filed with regulators

CytoSPAR filed one raise, $2.0M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Apr 2022$2.0M6 investorsequityof $5.0M offeredSEC Form D

Founders and team

From the SEC filings it signed: 1 on the team.

  • Russell WilliamsExecutive Officer, Directori

On the board, as filediMark AllenWilliam Weisman

Quick answers about CytoSPAR

How much has CytoSPAR raised?

CytoSPAR has raised $2.0M across 1 round since 2022.

When did CytoSPAR last raise?

CytoSPAR's most recent round was a Venture of $2.0M in May 2022.

What was CytoSPAR's biggest round?

Its most recent round, $2.0M in May 2022, is also its largest on record.

What stage is CytoSPAR at?

CytoSPAR's latest named round is a Venture, in May 2022.

Where is CytoSPAR based?

CytoSPAR is based in the United States.

Companies like CytoSPAR

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.